Rational assembly of bispecific antibodies
mAbs January 5, 2021
Cytotoxicity Sensitivity of Liver Cell Spheroids
Toxicology and Applied Pharmacology December 21, 2020
SLFN11 informs on standard of care and novel treatments in cancer models
British Journal of Cancer December 18, 2020
High Content Screen on hiPSC Hepatocytes
International Journal of Molecular Sciences December 15, 2020
Flow Cytometry, Automated Analysis and Reporting
Analyzing Developability of Novel Biotherapeutics
MAM Validation in Biopharma Process Characterization
Automated Site-Specific Glycosylation Monitoring of Biopharmaceuticals
Efficient MS-based Workflows for Glycoanalysis
Sensitive Sequence Variant Analysis in Biopharmaceuticals
Fostamatinib Efficacy in Patients with COVID-19 Lung Injury
Cell Reports Medicine October 29, 2020
Streamlining the Analysis of Compound Combination Screens
Network integration and modelling of dynamic drug responses at multi-omics levels
Communications Biology October 15, 2020
Streamlining SARS-CoV-2 Antibody Discovery at Twist Biopharma
Automating HT RT-qPCR Analysis
End-to-End Assay Automation
Applying Deep Learning for High Content Image Analysis
Automation of Nucleus Detection with Deep Learning
Novel Strategy for Detecting Low-Abundance HCPs
HTS for inhibitors of ChREBP-importin interaction
Biochemical Journal September 10, 2020
Interpretation of Mechanistic Screening Data
Protein Engineering: Bi- and Multi-Specifics, TCRs, and CAR Ts
Secure Data Is FAIR(er) Data
Anti-Tumor Activity of Pralatrexate in High-Risk Neuroblastoma
Oncotarget August 11, 2020
Tirzepatide is a biased dual GIP and GLP-1 agonist
JCI Insight July 31, 2020
NGS-Based Approaches in the Biopharma Development
End-to-End Workflow Platform for Integrated Biopharmaceutical Development
Merging Automation and Data Management Technology
Integrating Automated and Manual Cell Line Development Workflows
Allostery Within the Glucocorticoid Receptor
Science Advances July 17, 2020
Digitalizing Biopharma: R&D Innovation through Operational Excellence
Industrializing Immuno-Oncology Therapeutic Discovery Platforms
Design, Generation, and Evaluation of TCR-, TCR-Mimetic- and CAR-Based Therapeutics for Cancer Immunotherapy
Streamlining Large-Molecule Discovery Workflows
Industrializing Next-Gen Therapeutic Discovery Platforms
A Novel Data Processing Strategy for Detection of Low-Abundance HCPs
Screen for Enhancers of Nanoparticle mRNA Delivery
SLAS Discovery July 1, 2020
Using AI for High-Content Phenotypic Characterization
Data-Driven Decisions to Accelerate Biopharma R&D
